Evaluation of EC50 of factor VIII as predictor of prophylaxis efficacy in patients with severe haemophilia A-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of EC50 of factor VIII as predictor of prophylaxis efficacy in patients with severe haemophilia A

Published:2019-02 Issue: Volume:128 Page:215-221
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Fernández-Bello I.,Rode F.,Álvarez-Román M.T.,Butta N.V.,Rivas-Muñoz S.,Hernández-Moreno A.L.,de la Corte-Rodríguez H.,Martín-Salces M.,Larsen L.F.,Jiménez-Yuste V.

Funder

Novo Nordisk

Word Federation of Haemophilia

Spanish Society of Thrombosis and Haemostasis

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia;Ahnstrom;Haemophilia,2004

2. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group;Aledort;J. Intern. Med.,1994

3. Activity and activation of the complement system in patients being operated on for cancer of the colon;Baatrup;Eur. J. Surg.,1994

4. Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A;Bassus;Platelets,2006

5. Thrombin generation and phenotypic correlation in haemophilia A;Beltran-Miranda;Haemophilia,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP